As biosimilars reach the shelves, patients need pharmacists’ guidance

November 1, 2016

Patients will likely be introduced to biosimilars as cheaper versions of the biologic drugs—and they may assume the new products are “generics.” But while biosimilars are as clinically effective as the brand-name product and cost less, biosimilars are not exact replicas. As patients get accustomed to biosimilars, they will rely on their pharmacists’ knowledge.

BeMedWise Program at NeedyMeds, formerly the National Council on Patient Information and Education (NCPIE), encourages healthcare professionals and community groups to foster patient–professional communication about medicines. However, BeMedWise does not supervise or endorse the activities of any group or professional. Discussion and action concerning medicines are solely the responsibility of the patient and their healthcare professionals, and not BeMedWise.

Please consult a licensed health care professional with questions or concerns about your medication and/or condition.